Chronic low dose of AM404 ameliorates the cognitive impairment and pathological features in hyperglycemic 3xTg-AD mice

scientific article published on 13 November 2018

Chronic low dose of AM404 ameliorates the cognitive impairment and pathological features in hyperglycemic 3xTg-AD mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00213-018-5108-0
P932PMC publication ID6469654
P698PubMed publication ID30426182

P50authorGuey-Jen Lee-ChenQ88031050
P2093author name stringMing-Tsan Su
Shu-Ling Chen
Ying-Chieh Sun
Hsin-Yu Huang
Guan-Chiun Lee
Hsiu Mei Hsieh-Li
Hei-Jen Huang
P2860cites workWIN-55,212-2 chronically implanted into the CA3 region of the dorsal hippocampus impairs learning: a novel method for studying chronic, brain-area-specific effects of cannabinoids.Q51972188
Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse.Q52142981
Deciphering the role of ferulic acid against streptozotocin-induced cellular stress in the cardiac tissue of diabetic rats.Q52840409
[Alzheimer's disease and diabetes - the common pathogenesis].Q53132187
[Oxidative stress promotes hepatocyte apoptosis mediated by glycogen synthase kinase 3β].Q53648546
Hyperglycemia Enhances the Production of Amyloid β1-42 in the Lenses of Otsuka Long-Evans Tokushima Fatty Rats, a Model of Human Type 2 DiabetesQ38782401
Anandamide-induced endoplasmic reticulum stress and apoptosis are mediated by oxidative stress in non-melanoma skin cancer: Receptor-independent endocannabinoid signalingQ38823998
17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner.Q40021016
Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25-35 peptide administration in miceQ40527526
Insulin resistance-induced hyperglycemia decreased the activation of Akt/CREB in hippocampus neurons: Molecular evidence for mechanism of diabetes-induced cognitive dysfunctionQ40568267
Neurobiology of Alzheimer's diseaseQ41864156
Delta9-tetrahydrocannabinol (THC) and AM 404 protect against cerebral ischaemia in gerbils through a mechanism involving cannabinoid and opioid receptorsQ42178082
Intracellular accumulation of amyloid-β (Aβ) protein plays a major role in Aβ-induced alterations of glutamatergic synaptic transmission and plasticity.Q42465835
Axonopathy and transport deficits early in the pathogenesis of Alzheimer's diseaseQ42474769
Beta-secretase protein and activity are increased in the neocortex in Alzheimer diseaseQ44132132
Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide].Q44719973
Streptozotocin-induced diabetes increases amyloid plaque deposition in AD transgenic mice through modulating AGEs/RAGE/NF-κB pathwayQ44969807
Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axisQ45032434
Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404.Q46163967
AM404, paracetamol metabolite, prevents prostaglandin synthesis in activated microglia by inhibiting COX activityQ46241956
Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned ratsQ46426993
Activation of endocannabinoid transmission induces antidepressant-like effects in rats.Q46487164
Augmentation of endogenous cannabinoid tone modulates lipopolysaccharide-induced alterations in circulating cytokine levels in ratsQ46660450
Insulin degrading enzyme contributes to the pathology in a mixed model of Type 2 diabetes and Alzheimer's disease: possible mechanisms of IDE in T2D and AD.Q47313449
Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential linkQ47381948
Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent propertiesQ48324018
Cannabinoids modulate hippocampal memory and plasticityQ48433767
Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain SectionsQ48764154
Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic miceQ48846848
Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic miceQ48901829
Hyperglycemia Increases the Production of Amyloid Beta-Peptide Leading to Decreased Endothelial Tight JunctionQ48930602
Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signalingQ50113929
Alzheimer's DiseaseQ22248111
Global prevalence of dementia: a Delphi consensus studyQ24603249
Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodentsQ24613945
Endogenous cannabinoid signaling is essential for stress adaptationQ24631883
Neuropathological stageing of Alzheimer-related changesQ27860862
Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous systemQ28182188
New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometryQ28290064
Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunctionQ29547778
Palmitate Increases β-site AβPP-Cleavage Enzyme 1 Activity and Amyloid-β Genesis by Evoking Endoplasmic Reticulum Stress and Subsequent C/EBP Homologous Protein ActivationQ33556064
A phase II trial of tideglusib in Alzheimer's diseaseQ34042842
Staging of Alzheimer's pathology in triple transgenic mice: a light and electron microscopic analysisQ34078130
The role of tau kinases in Alzheimer's diseaseQ34138413
Pharmacology of cannabinoid CB1 and CB2 receptors.Q34442847
Chronic temporal lobe epilepsy is associated with enhanced Alzheimer-like neuropathology in 3×Tg-AD miceQ34479091
Endothelial nitric oxide modulates expression and processing of amyloid precursor proteinQ34720034
The GSK3 signaling pathway is activated by cocaine and is critical for cocaine conditioned reward in miceQ35088414
The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer diseaseQ35944243
Exendin-4 protected against cognitive dysfunction in hyperglycemic mice receiving an intrahippocampal lipopolysaccharide injection.Q36109697
Administration of NaHS Attenuates Footshock-Induced Pathologies and Emotional and Cognitive Dysfunction in Triple Transgenic Alzheimer's MiceQ36316228
GSK3β inhibition protects the immature brain from hypoxic-ischaemic insult via reduced STAT3 signallingQ36378223
Genetic targeting aromatase in male amyloid precursor protein transgenic mice down-regulates beta-secretase (BACE1) and prevents Alzheimer-like pathology and cognitive impairmentQ36423441
Chronic hyperglycemia induced via the heterozygous knockout of Pdx1 worsens neuropathological lesion in an Alzheimer mouse modelQ37089126
Impaired glycemia increases disease progression in mild cognitive impairmentQ37489320
Identifying GSK-3β kinase inhibitors of Alzheimer's disease: Virtual screening, enzyme, and cell assaysQ38776993
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue2
P921main subjecthyperglycemiaQ271993
cognitive dysfunctionQ57859955
P304page(s)763-773
P577publication date2018-11-13
P1433published inPsychopharmacologyQ1422802
P1476titleChronic low dose of AM404 ameliorates the cognitive impairment and pathological features in hyperglycemic 3xTg-AD mice
P478volume236

Reverse relations

Q92535276Neuroprotective Effect of AM404 Against NMDA-Induced Hippocampal Excitotoxicitycites workP2860

Search more.